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Respected Editor,
Carbon monoxide (CO), a leading cause of poisoning, 
causes its noxious effects by depriving the living tissues 
of Oxygen (O2). It does so by binding to hemoglobin 
(Hb) with a significantly higher affinity than O2. The 
resulting Carboxyhemoglobin (COHb) decreases the 
blood’s O2 carrying capacity and even impairs the 
release of O2 from Hb  [1]. As organs’ vitality becomes 
progressively compromised, the symptoms of CO 
poisoning aggravate from vague complaints such as 
headache, dizziness, blurred vision, nausea and       
vomiting to hypotension, arrhythmias, cardiac and 
respiratory arrest, seizures, and ultimately coma  [1]. 
The most toxic amounts of CO typically exist in indoor 
air. Wood burning stoves, furnaces, inappropriately              
adjusted gas appliances, improperly vented gas
generators inside a house or building are potential 
contributors to CO poisoning [2].
Oxygen therapy delivered via a non-rebreather mask or 
endotracheal tube has historically been the mainstay of 
treatment in CO poisoning. Hyperbaric Oxygen therapy 
has also been suggested, especially in severe cases, 
with evidence supporting the fact that it lowers the 
half-life of CO faster than normobaric oxygen. However, 
its use is severely limited due to cost constraints, lack of 
expertise, and the undersupply of equipment, even 
more so in the developing world [1]. A relatively new 
approach is being investigated, which involves                
delivering continuous positive airway pressure (CPAP) 
through non-invasive mechanical ventilation [3-5].       
The resulting positive pressure in the airways improves 
the exchange of gases and leads to a rise in alveolar 
pressure. The increased inspiratory and expiratory                                                    
pressures in the alveoli, in turn, have a favorable impact 
on the ventilation/perfusion ratio, which is hypothesized 
to cause an increase in the partial pressure of O2, 
increased O2 binding with hemoglobin, and CO                                       
decomposition [4].
Turgut et al. [3] compared the lowering of CO between 
patients given 15 L/min O2 via non-rebreather mask 
and patients given FiO2 100% via CPAP. In this study, 
they observed a statistically significant lowering of CO
at 30, 60, and 90 minutes with CPAP compared to 
normobaric O2. Furthermore, the duration of stay in the 
Emergency department decreased from a median of 
185 minutes to 125 minutes in normobaric Oxygen and 
CPAP groups, respectively. The half-life of CO was also 
lowered from a median of 105 minutes in the normobaric 
oxygen group to 45 minutes in the CPAP group [3]. 
Another study by Bal et al. [4] comparing the efficacy of 
10 L/min O2 vs. CPAP found a similar decline in the 
half-life of COHb using CPAP i.e. 80.26 ± 12.70 minutes 
for O2 therapy vs. 36.20 ± 4.58 minutes for CPAP. As 
obtained by venous samples, the blood CO levels were 
also significantly lower in the CPAP group at 30 and 60 
minutes [4]. Caglar et al. [5] further reported that CPAP 
was superior to high-flow O2 therapy to lower the COHb 
saturation within the first 30 min of treatment. The 
median lowering of COHb was 13% in the CPAP group 
and 6% in the patients on O2 therapy, as shown by the 
CO-oximeter. However, both treatment modalities 
provided approximately similar relief of symptoms such 
as headache and nausea, with CPAP showing a slight 
benefit in lowering headaches [5].
The studies mentioned above are, however, limited
by their small sample sizes. Thus, large-scale studies 
are needed to establish the role of CPAP in acute
CO poisoning. Since the trials largely excluded vitally 
unstable patients with complications and high blood
CO levels, no effective conclusion can be drawn
regarding CPAP’s efficacy in severe CO poisoning. 
Sufficient data to suggest its impact on mortality and 
long-term neurocognitive effects is also lacking. Thus, 
these areas require further investigation. Despite these 
gaps, we can conjecture that the use of CPAP may 
facilitate a rapid lowering of COHb levels and, quite 
possibly, better symptom control and earlier discharge 
from the emergency department.
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